|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,166.30 INR | -0.01% |
|
-1.92% | -12.33% |
| Capitalization | 37TCr 385.11Cr 333.5Cr 306.01Cr 287.91Cr 536.23Cr 544.62Cr 3.64TCr 1.42TCr 18TCr 1.45TCr 1.41TCr 62TCr | P/E ratio 2026 |
37.3x | P/E ratio 2027 * | 32.2x |
|---|---|---|---|---|---|
| Enterprise value | 37TCr 385.11Cr 333.5Cr 306.01Cr 287.91Cr 536.23Cr 544.62Cr 3.64TCr 1.42TCr 18TCr 1.45TCr 1.41TCr 62TCr | EV / Sales 2026 |
10.1x | EV / Sales 2027 * | 8.75x |
| Free-Float |
24.36% | Yield 2026 |
2.5% | Yield 2027 * | 1.36% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -0.01% | ||
| 1 week | -1.92% | ||
| Current month | -1.92% | ||
| 1 month | -10.64% | ||
| 3 months | -13.79% | ||
| 6 months | -14.82% | ||
| Current year | -12.33% |
| 1 week | 2,155 |  | 2,217.25 |
| 1 month | 2,155 | | 2,505 |
| Current year | 2,155 | | 2,715.15 |
| 1 year | 2,155 | | 3,500 |
| 3 years | 1,359.55 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
Som Somasundaram
BRD | Director/Board Member | 65 | 26/03/2025 |
Manu Anand
BRD | Director/Board Member | 66 | 16/05/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | -1.92% | -36.87% | +56.15% | 385.11Cr | |
| +0.55% | +2.39% | +46.96% | +155.36% | 1,00900Cr | |
| +2.02% | +3.30% | +50.15% | +47.16% | 56TCr | |
| +1.02% | +4.37% | +19.70% | +67.78% | 40TCr | |
| +0.77% | -0.67% | +21.96% | +11.96% | 33TCr | |
| +2.24% | +0.41% | +28.53% | +17.12% | 29TCr | |
| +1.85% | +0.14% | +21.53% | +30.34% | 27TCr | |
| +4.43% | -3.11% | -42.11% | -49.56% | 19TCr | |
| +1.15% | +3.80% | +20.41% | +58.02% | 19TCr | |
| -0.02% | -3.92% | +14.85% | +69.50% | 16TCr | |
| Average | +1.40% | +0.83% | +14.51% | +46.38% | 34.05TCr | |
| Weighted average by Cap. | +1.34% | +1.94% | +30.11% | +70.52% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 3.89TCr 41Cr 35Cr 32Cr 30Cr 57Cr 58Cr 385.08Cr 149.87Cr 1.88TCr 153.09Cr 149.75Cr 6.53TCr | 4.19TCr 44Cr 38Cr 35Cr 33Cr 61Cr 62Cr 415.68Cr 161.78Cr 2.03TCr 165.25Cr 161.66Cr 7.05TCr |
| Net income | 1.04TCr 11Cr 9.49Cr 8.71Cr 8.19Cr 15Cr 15Cr 103.51Cr 40Cr 505.03Cr 41Cr 40Cr 1.76TCr | 1.14TCr 12Cr 10Cr 9.51Cr 8.94Cr 17Cr 17Cr 113.01Cr 44Cr 551.39Cr 45Cr 44Cr 1.92TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 2,166.30 ₹ | -0.01% | 2,381 |
| 04/26/04 | 2,166.50 ₹ | -0.60% | 1,522 |
| 03/26/03 | 2,179.65 ₹ | -0.40% | 1,887 |
| 02/26/02 | 2,188.30 ₹ | -0.70% | 4,950 |
| 01/26/01 | 2,203.65 ₹ | -0.23% | 5,107 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 500660 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition